Search Results - "Alonso Galán, H"

P949 Effectiveness and safety of rectal tacrolimus in patients with ulcerative colitis. TACRO-TOPIC study. A multicenter study from the young group of GETECCU by Fuentes-Valenzuela, E, Bastón-Rey, I, García-Alonso, F J, Leo Carnerero, E, Garcia de la Filia, I, Pedraza Pérez, A, Sáiz Chumillas, R M, Pascual Oliver, A, Muñoz Villafranca, C, Moreno, V, Suárez Ferrer, C, Molina Arriero, G, Ferreiro-Iglesias, R, Vega Villaamil, P, Gardeazábal Mateos, D, Segarra-Ortega, J X, Garrido Marín, A, Doallo, A I, Elosua, A, Alonso-Galán, H, Brunet- Mas, E, Jimenez García, N, López Romero-Salazar, F, Velayos, B, Carballo-Folgoso, L, Pérez Santamaría, C, Mata Román, L, Núñez Ortiz, A, Barrio, J, Barreiro-de Acosta, M, Gutiérrez-Casbas, A

“…Abstract Background Few small studies have assessed the efficacy of topical therapy with tacrolimus in patients with ulcerative colitis (UC). The aim of our…”
Get full text

P1170 Long-term outcomes of newly diagnosed Inflammatory Bowel Disease (IBD) patients: results from the nationwide EpidemIBD study of GETECCU by Chaparro, M, Garre, A, Núñez Ortiz, A, Rubio, S, Diz-Lois Palomares, M T, Riestra, S, Alonso-Galán, H, Fernández-Salgado, E, Ferreiro-Iglesias, R, Vela, M, Ponferrada Díaz, Á, Sánchez Rodríguez, E, Hernández, V, Arias García, L, Barrio, J, Huguet, J M, Ginard, D, Rivero, M, Vera, I, Alonso-Abreu, I, Benítez, J M, Aguas, M, Rodríguez-Lago, I, Calvet, X, Fernández-Salazar, L, Echarri, A, Arroyo, M T, Navarro-Llavat, M, Vega, P, Sierra, M, Guerra del Río, E, Vicente, R, Casanova, M J, Navarro, P, Ortiz de Zarate, J, Varela Trastoy, P, Spicakova, K, Gutiérrez, A, Martín-Arranz, M D, Gisbert, J P

“…Abstract Background Aims: 1) To describe the main epidemiological and clinical characteristics of patients at IBD diagnosis and the long-term outcomes; 2) to…”
Get full text

P569 Persistence and safety of upadacitinib in Crohn’s disease and ulcerative colitis in real life: results from a Spanish nationwide study by García, M J, Brenes, Y, Vicuña, M, Bermejo, F, Sierra-Ausín, M, Polo Cuadro, C, Arroyo, M T, Martínez Montiel, P, Villoria, A, Pérez-Calle, J L, Hernandez, V, Piñero, A, Carrillo-Palau, M, Martín-Arranz, M D, Miranda-Bautista, J, Pajares, R, Arranz Hernández, L, Bejarano, A, Guardiola, J, Iyo, E, Muñoz-Villafranca, C, Talavera, A, Alonso-Galán, H, Barreiro-de Acosta, M, Bosca-Watts, M, Vázquez Rey, T, Echarri, A, Rodríguez-Grau, M D C, Gutiérrez, A, Huguet, J M, López-Martín, M C, Mesonero, F, Pérez-Martínez, I, Plaza, R, Ramírez de la Piscina, P, Gisbert, J P, Chaparro, M

“…Abstract Background Upadacitinib (UPA) has demonstrated its efficacy in patients with inflammatory bowel disease (IBD) in clinical trials. However, these…”
Get full text

DOP74 Short and long-term effectiveness and safety of ustekinumab in Ulcerative Colitis in real life: the ULISES study by Chaparro, M, Hermida, S, Acosta, D, Fernández-Clotet, A, Barreiro-de Acosta, M, Hernández Martínez, Á, Arroyo, M, Bosca-Watts, M M, Diz-Lois Palomares, M T, Menchén, L, Martínez Cadilla, J, Leo-Carnerero, E, Muñoz Villafranca, C, Sierra-Ausín, M, González, Y, Riestra, S, Sendra Rumbeu, P, Cabello Tapia, M J, García de la Filia, I, Montil Miguel, E, Ceballos, D, Pajares Villarroya, R, Ramírez de la Piscina, P, Martín-Arranz, M D, Ramos, L, Ruiz-Cerulla, A, Teresa de Jesús, M P, San Miguel, E, Calvet, X, Huguet, J M, Keco-Huerga, A, Lorente Poyatos, R H, Muñoz, J F, Ponferrada, Á, Sicilia Aladrén, B, Delgado-Guillena, P, Gómez Delgado, E, Rancel-Medina, F J, Alonso-Galán, H, Gisbert, J P

“…Abstract Background Primary aim: To assess the durability of ustekinumab treatment in patients with ulcerative colitis (UC). Secondary aims: To assess the…”
Get full text

P675 Real world evidence of tofacinitib in ulcerative colitis: short and long-term effectiveness, safety and impact of extraintestinal manifestations and immunomediated diseases by Chaparro, M, Acosta, D, Rodríguez, C, Mesonero, F, Vicuña, M, Barreiro-de Acosta, M, Fernández-Clotet, A, Hernández Martínez, Á, Arroyo, M, Vera, I, Ruiz-Cerulla, A, Sicilia, B, Cabello Tapia, M J, Muñoz Villafranca, C, Castro-Poceiro, J, Martínez Cadilla, J, Sierra-Ausín, M, Vázquez Morón, J M, Montil Miguel, E, Bermejo, F, Royo, V, Calafat, M, González-Muñoza, C, Leo Carnerero, E, Manceñido Marcos, N, Torrealba, L, Alonso-Galán, H, Benítez, J M, Ber Nieto, Y, Diz-Lois Palomares, M T, García, M J, Muñoz, J F, Armesto González, E M, Calvet, X, Hernández-Camba, A, Madrigal Domínguez, R E, Menchén, L, Pérez Calle, J L, Piqueras, M, Gisbert, J P

“…Abstract Background Main aim: To assess the durability of tofacitinib treatment in patients with ulcerative colitis (UC). Secondary aims: To assess the short…”
Get full text

DOP04 Inflammatory Bowel Disease (IBD) and Solid Organ Transplantation. Natural history of pre-existing and de novo IBD patients. (EITOS study of GETECCU) by Bastón Rey, I, Calvino Suárez, C, Luque, A M, Caballol, B, Soutullo, C, Bravo, A, Castaño, A, Gros, B, Bernal, L, Diz Lois, M T, Alonso Galán, H, Cañete, F, Castro, B, Pérez Galindo, P, González Muñoza, C, El Hajra, I, Martínez Montiel, P, Alonso Abreu, I, Mesonero, F, González Vivo, M, Peries, L, Martín Arranz, E, Abril, C, Marín Jiménez, I, Baltar, R, Vicuna, M, Moreno, N, Brunet, E, Rubín de Célix, C, Fajardo, I, Cruz, N, Rojas Feria, M, Fernández Clotet, A, Gimeno, M, Zabana, Y, Suárez Ferrer, C, Rodríguez Lago, I, Barreiro de Acosta, M

“…Abstract Background Limited data is available of the outcome of inflammatory bowel disease (IBD) in patients with solid organ transplantation (SOT). The aim of…”
Get full text

P373 Real world evidence of tofacinitib in ulcerative colitis: short and long-term effectiveness, impact of extraintestinal manifestations and immunomediated diseases and safety by Chaparro, M, Acosta, D, Rodríguez, C, Vicuña, M, Mesonero, F, Barreiro-de Acosta, M, Fernández-Clotet, A, Hernández Martínez, Á, Arroyo, M T, Vera Mendoza, I, Sicilia, B, Muñoz Villafranca, C, Castro-Poceiro, J, Martínez Cadilla, J, Vázquez Morón, J M, Montil, E, Sierra-Ausín, M, Calafat, M, Leo Carnerero, E, Manceñido Marcos, N, Torrealba M, L, Alonso-Galán, H, Benítez, J M, Ber Nieto, Y, Cabello Tapia, M J, Diz-Lois Palomares, M T, García, M J, Armesto González, E M, Calvet Calvo, X, Piqueras, M, Dueñas Sadornil, C, Pérez Calle, J L, Botella, B, Martínez-Pérez, T D J, Ramos, L, Rodríguez-Grau, M C, Fernández Forcelledo, J L, Gutiérrez, A, Sesé Abizanda, E, Gisbert, J P

“…Abstract Background Main aim: To assess the retention rate of tofacitinib treatment in patients with ulcerative colitis (UC). Secondary aims: To assess the…”
Get full text

P349 Safety of Inflammatory Bowel Disease treatments in patients with Solid Organ Transplantation (EITOS study of GETECCU) by Bastón Rey, I, Calvino Suárez, C, Luque, A M, Caballol, B, Soutullo, C, Bravo, A, Castaño, A, Gros, B, Hurtado, A, Vázquez Rey, T, Alonso Galán, H, Cañete, F, Castro, B, Pérez Galindo, P, González Muñoza, C, El Hajra, I, Martínez Montiel, P, Alonso Abreu, I, Mesonero, F, González Vivo, M, Peries, L, Martín Arranz, E, Abril, C, Marín Jiménez, I, Baltar, R, Vicuña, M, Moreno, N, Brunet, E, Rodríguez Lago, I, Rubín de Célix, C, Fajardo, I, Cruz, N, Rojas Feria, M, Fernández Clotet, A, Gimeno, M, Zabana, Y, Suárez Ferrer, C, Barreiro de Acosta, M

“…Abstract Background Inflammatory bowel disease (IBD) in patients with solid organ transplantation (SOT) is associated with a greater complexity in their…”
Get full text

OP20 Risk and predictors of surgery in a newly diagnosed cohort of IBD patients in the biologic era: Results from the EpidemIBD study by Chaparro, M, Garre, A, Núñez Ortiz, A, Diz-Lois Palomares, M T, Rodríguez, C, Riestra, S, Vela, M, Benítez, J M, Fernández Salgado, E, Sánchez Rodríguez, E, Hernández, V, Ferreiro-Iglesias, R, Ponferrada Díaz, Á, Barrio, J, Huguet, J M, Arias, L, Martín-Arranz, M D, Calvet, X, Ginard, D, Alonso-Abreu, I, Fernández-Salazar, L, Varela Trastoy, P, Rivero, M, Vera-Mendoza, I, Vega, P, Navarro, P, Sierra, M, Cabriada, J L, Aguas, M, Vicente, R, Navarro-Llavat, M, Echarri, A, Gomollón, F, Guerra del Río, E, Casanova, M J, Spicakova, K, Ortiz de Zarate, J, Alonso-Galán, H, Barreiro-de Acosta, M, Gisbert, J P

“…Abstract Background The management of inflammatory bowel disease (IBD) has substantially changed in the last decades, both in relation to medical and surgical…”
Get full text

P481 Profile of elderly patients in which biological drugs are used for the treatment of inflammatory bowel disease by Suarez Ferrer, C J, Mesonero, F, Caballol, B, Ballester, M P, Baston Rey, I, Castaño Garcia, A, Miranda Bautista, J, Saiz Chumillas, R, Benitez, J M, Sanchez Delgado, L, Lopez-Garcia, A, Rubin de Celio, C, Alonso Abreu, I, Melcarne, L, Plaza Santos, R, Marques Cami, M, Caballero Mateos, A, Gomez Diez, C, Calafat, M, Alonso Galan, H, Vega Vilaamil, P, Castro Sensosian, B, Guerro Moya, A, Rodriguez Diaz, C Y, Spicakova, K, Manceñido Marcos, N, Molina, G, De Castro, L, Rodriguez Angulo, A, Cuevas del Campo, L, Rodriguez Grau, M C, Ramirez, F, Gomez Pastrana, B, Gonzalez Partida, I, Botella Mateu, B, Peña Gonzalez, E, Iyo, E, Elosua Gonzalez, A, Mañosa Ciria, M, Barreiro-De Acosta, M

“…Abstract Background The use of biological drugs for the treatment of IBD in elderly patients is becoming more frequent in our environment. However, given the…”
Get full text

P410 Safety of biological drugs for inflammatory bowel disease in elderly patients by Suarez Ferrer, C J, Mesonero, F, Caballol, B, Ballester, M P, Baston Rey, I, Castaño Garcia, A, Miranda Bautista, J, Saiz Chumillas, R, Benitez, J M, Sanchez Delgado, L, Lopez-Garcia, A, Rubin de Celix, C, Lopez Sanroma, A, Martin-Arranz, M D, Fernández-Clotet, A, Merino Murgui, V, Calviño Suárez, C, Florez, P, Lobato matilla, M E, Sicilia, B, Soto Escribano, P, Maroto Martin, C, Alonso Abreu, I, Melcarne, L, Plaza Santos, R, Marques Cami, M, Caballero Mateos, A, Gómez Díez, C, Calafat, M, Alonso Galan, H, Vega Villaamil, P, Castro Senosiain, B, Guerro Moya, A, Rodriguez Diaz, C Y, Spicakova, K, Manceñido Marcos, N, Molina, G, De Castro, L, Mañosa Ciria, M, Barreiro-De Acosta, M

“…Abstract Background The most feared adverse events related to biological treatment in patients with inflammatory bowel disease (IBD) are the development of…”
Get full text

P338 effectiveness and safety of biological therapies in elderly inflammatory bowel diseases patients results from a multi center study of Geteccu by Suarez Ferrer, C J, Mesonero, F, Caballol, B, Saiz Chumillas, R, Bastón-Rey, I, Rubin de Celix, C, Melcarne, L, Caballero Mateos, A, Calafat, M, Alonso Galan, H, Vega Villaamil, P, Castro Senosiain, B, Rodriguez Diaz, C Y, Plaza Santos, R, Marques Cami, M, Rodriguez Grau, M C, Ramirez, F, Lopez-García, A, Gomez Pastrana, B, Gonzalez Partida, I, Botella Mateu, B, Cuevas del Campo, L, Gonzalez Peña, E, Iyo, E, Elosua Gonzalez, A, Sainz, E, Hernandez, L, Perez Galindo, P, Rueda Garcia, J L, Martin-Arranz, M D, Lopez Sanroman, A, Fernandez-Clotet, A, Sicilia, B, Calviño Suárez, C, Mañosa Ciria, M, Barreiro-De Acosta, M

“…Abstract Background Biological drugs are being increasingly used for the treatment of inflammatory bowel diseases (IBD) in elderly patients. Despite the…”
Get full text